DCF Valuation

UnitedHealth Group Incorporated (UNH) DCF Valuation — Is UNH undervalued?

The estimated DCF fair value of one UnitedHealth Group Incorporated (UNH) share is $804.48. Compared to the current market price of $412.75, the stock is undervalued by 94.9%.

DCF fair value

$804.48

Market price

$412.75

Upside / downside

+94.9%

Run the full interactive DCF model →

Prefer the inverse question? See what growth rate the market is pricing into UNH

UnitedHealth Group Incorporated (UNH) DCF valuation FAQ

What is the DCF fair value of UnitedHealth Group Incorporated (UNH)?

The discounted-cash-flow model estimates the intrinsic fair value of one UnitedHealth Group Incorporated (UNH) share at $804.48, based on a 10-year projection of its cash flows converging to Damodaran industry averages.

Is UnitedHealth Group Incorporated (UNH) overvalued or undervalued?

Against the current market price of $412.75, the DCF fair value of $804.48 implies UNH is undervalued by 94.9%.

How is the UNH DCF value calculated?

It is a 10-year discounted-cash-flow estimate built from UnitedHealth Group Incorporated's reported fundamentals, with terminal assumptions anchored to Damodaran NYU industry datasets. The market price refreshes daily; the DCF fair value updates when UnitedHealth Group Incorporated files a new quarterly or annual report.

How this UNH valuation is built

The model projects ten years of UnitedHealth Group Incorporated's free cash flow to the firm and discounts each year at its own cost of capital. Rather than assuming today's growth and margins persist forever, a moat-scoring step — weighing UnitedHealth Group Incorporated's ROIC-versus-WACC spread, gross-margin trend, and reinvestment efficiency — decides how many years the business holds its edge before its economics mean-revert toward the Damodaran NYU benchmarks for its industry.

WACC is rebuilt each year from an unlevered-then-relevered beta and the company's evolving capital structure; terminal value uses the Gordon growth model with a reinvestment rate tied to the return earned on new capital (goodwill stripped out to reflect operating efficiency). Every assumption — growth, margins, tax, leverage, convergence timing — is editable, and running the full interactive model adds a 10,000-draw Monte Carlo simulation and WACC-versus-terminal-growth sensitivity heatmaps.

The market price refreshes daily; the DCF fair value updates when UnitedHealth Group Incorporated files a new quarterly or annual report. For educational/informational purposes only — not investment advice. Last updated 2026-08-06.